Shanghai Fosun Pharma Industrial Development

Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. is the primary industrial and R&D subsidiary of Fosun Pharma, a leading global innovation-driven healthcare group. Headquartered in Shanghai, the company focuses on the development, manufacturing, and commercialization of innovative drugs and high-value generics across oncology, immunology, infectious diseases, and the central nervous system. It operates advanced technology platforms for small molecules, monoclonal antibodies, and antibody-drug conjugates (ADCs), supporting a robust pipeline of over 70 projects. Key products include the PD-1 inhibitor serplulimab and the world-leading antimalarial treatment artesunate. The company leverages a global R&D network and strategic partnerships with international firms like BioNTech and Kite Pharma to bring cutting-edge therapies to market.